ACCADRINE-Ac-262-536 15mg – Beligas USA

Description ACCADRINE (AC-262,536) is a non-steroidal Selective Androgen Receptor Modulator (SARM) developed to stimulate muscle growth while minimizing androgenic side effects. It is manufactured by Beligas Pharmaceuticals in a 15mg tablet form. Key Features Anabolic Profile: It is a partial agonist of the androgen receptor, achieving a portion of the muscle-building potential of testosterone, with a significantly lower effect on the prostate, according to studies. Targeted Use: Primarily utilized by individuals seeking to increase lean muscle mass and bone density without the significant side effects, like prostate enlargement, associated with traditional steroids. Mechanics: It has a high affinity for muscle and bone tissue while remaining relatively inactive in reproductive tissues. Safety & Side Effects Liver Health: Like many oral SARMs, there is a risk of drug-induced liver injury or elevated liver enzymes. Hormonal Impact: While less suppressive than steroids, it can still suppress natural testosterone and Luteinizing Hormone (LH) levels. Regulatory Status: Not approved by the FDA for human use and is strictly banned by WADA and most professional sports organizations. Product Details Composition: It is commonly found in tablet form, with varied concentrations depending on the manufacturer. Duration: Often used in cycles, though long-term human safety data is limited.